NMRD logo

Nemaura Medical (NMRD) EBITDA

Annual EBITDA

-$7.29 M
+$53.50 K+0.73%

March 31, 2023

Summary

Performance

1-Year Change

+0.73%

3-Year Change

-54.27%

5-Year Change

-287.67%

15-Year Change

-376.03%

NMRD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.37%
NMRD annual EBITDA is higher than 68.37% of companies in Healthcare sector

High & Low

All-time High

-$581.10 K

3-Year Low

-$7.34 M

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2023
NMRD previous annual earnings announcement was published on Mar 31, 2023

Next Annual Earnings Report Date

Mar 4, 2025
NMRD next annual earnings announcement is scheduled for Mar 4, 2025

OtherNMRDprofitabilitymetrics:

Annual Revenue

$77.00 K
NMRD annual revenue is $77.00 thousand

Annual Net Income

-$14.14 M
NMRD annual net profit is -$14.14 million

Annual EBIT

-$7.73 M
NMRD annual earnings before interest & taxes is -$7.73 million

Annual EPS

-$0.57
NMRD annual earnings per share is -$0.57

Quarterly EBITDA

-$155.40 K
+$92.10 K+37.21%

December 31, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+85.07%

5-Year Change

+83.12%

NMRD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.66%
NMRD quarterly EBITDA is higher than 74.66% of companies in Healthcare sector

High & Low

All-time High

-$21.80 K

3-Year Low

-$2.35 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
NMRD previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

Mar 4, 2025
NMRD next earnings announcement is scheduled for Mar 4, 2025

OtherNMRDprofitabilitymetrics:

Quarterly Revenue

-
NMRD quarterly revenue value is unknown

Quarterly Net Income

-$2.16 M
NMRD quarterly net profit is -$2.16 million

Quarterly EBIT

-$235.80 K
NMRD quarterly earnings before interest & taxes is -$235.80 thousand

Quarterly EPS

-$0.07
NMRD quarterly earnings per share is -$0.07

TTM EBITDA

-$4.50 M
+$382.00 K+7.83%

December 31, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-0.44%

5-Year Change

+9.98%

NMRD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.59%
NMRD TTM EBITDA is higher than 71.59% of companies in Healthcare sector

High & Low

All-time High

-$61.10 K

3-Year Low

-$8.59 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
NMRD previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

Mar 4, 2025
NMRD next earnings announcement is scheduled for Mar 4, 2025

OtherNMRDprofitabilitymetrics:

TTM Revenue

-
NMRD TTM revenue value is unknown

TTM Net Income

-$10.65 M
NMRD TTM net profit is -$10.65 million

TTM EBIT

-$4.98 M
NMRD TTM earnings before interest & taxes is -$4.98 million

TTM EPS

-$0.39
NMRD TTM earnings per share is -$0.39

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$7.29 M
NMRD annual EBITDA is -$7.29 million

Annual Net Income

-$14.14 M
NMRD annual net profit is -$14.14 million

Annual Interest Expense

$6.41 M
NMRD annual interest expense is $6.41 million

Annual Income Tax

$0.00
NMRD annual income tax is $0.00

Annual D&A

$444.20 K
NMRD annual depreciation & amortization is $444.20 thousand

NMRD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.7%0.0%0.0%
3 y3 years-54.3%+85.1%-0.4%
5 y5 years-287.7%+83.1%+10.0%

NMRD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-62.3%+0.7%at high+93.4%at high+47.6%
5 y5-year-64.0%+0.7%at high+93.4%-2.9%+47.6%
alltimeall time-1154.0%+0.7%-612.8%+93.4%-7262.0%+47.6%

Nemaura Medical EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-
-$155.40 K(-37.2%)
-$4.50 M(-7.8%)
Sep 2023
-
-$247.50 K(-86.6%)
-$4.88 M(-28.2%)
Jun 2023
-
-$1.85 M(-17.8%)
-$6.80 M(-6.7%)
Mar 2023
-$7.29 M(-0.7%)
-$2.25 M(+318.2%)
-$7.29 M(-1.4%)
Dec 2022
-
-$537.40 K(-75.2%)
-$7.39 M(-13.9%)
Sep 2022
-
-$2.16 M(-7.4%)
-$8.59 M(+6.1%)
Jun 2022
-
-$2.34 M(-0.6%)
-$8.09 M(+10.3%)
Mar 2022
-$7.34 M(+63.5%)
-$2.35 M(+35.6%)
-$7.34 M(+15.8%)
Dec 2021
-
-$1.73 M(+3.9%)
-$6.34 M(+12.3%)
Sep 2021
-
-$1.67 M(+5.3%)
-$5.64 M(+8.9%)
Jun 2021
-
-$1.58 M(+17.4%)
-$5.18 M(+15.5%)
Mar 2021
-$4.49 M(-5.0%)
-$1.35 M(+29.7%)
-$4.49 M(+0.2%)
Dec 2020
-
-$1.04 M(-13.8%)
-$4.48 M(+0.0%)
Sep 2020
-
-$1.21 M(+35.5%)
-$4.48 M(+2.5%)
Jun 2020
-
-$890.90 K(-33.5%)
-$4.37 M(-7.5%)
Mar 2020
-$4.72 M(+6.3%)
-$1.34 M(+28.8%)
-$4.72 M(-5.5%)
Dec 2019
-
-$1.04 M(-5.4%)
-$5.00 M(+2.4%)
Sep 2019
-
-$1.10 M(-11.6%)
-$4.88 M(-0.9%)
Jun 2019
-
-$1.24 M(-22.9%)
-$4.92 M(+10.8%)
Mar 2019
-$4.44 M
-$1.61 M(+75.2%)
-$4.44 M(+31.0%)
Dec 2018
-
-$920.70 K(-19.6%)
-$3.39 M(+15.4%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$1.14 M(+49.6%)
-$2.94 M(+31.7%)
Jun 2018
-
-$765.20 K(+36.4%)
-$2.23 M(+18.8%)
Mar 2018
-$1.88 M(+22.8%)
-$561.00 K(+19.6%)
-$1.88 M(+12.3%)
Dec 2017
-
-$468.90 K(+7.2%)
-$1.67 M(+6.2%)
Sep 2017
-
-$437.60 K(+6.1%)
-$1.58 M(+8.3%)
Jun 2017
-
-$412.30 K(+16.3%)
-$1.45 M(-5.0%)
Mar 2017
-$1.53 M(+0.6%)
-$354.40 K(-4.4%)
-$1.53 M(-3.7%)
Dec 2016
-
-$370.80 K(+17.2%)
-$1.59 M(+3.0%)
Sep 2016
-
-$316.40 K(-35.3%)
-$1.54 M(-4.3%)
Jun 2016
-
-$489.30 K(+18.5%)
-$1.61 M(+6.0%)
Mar 2016
-$1.52 M(+16.0%)
-$412.80 K(+26.9%)
-$1.52 M(-7.4%)
Dec 2015
-
-$325.20 K(-15.6%)
-$1.64 M(+11.5%)
Sep 2015
-
-$385.50 K(-3.3%)
-$1.47 M(+2.1%)
Jun 2015
-
-$398.70 K(-25.3%)
-$1.44 M(+10.0%)
Mar 2015
-$1.31 M(+125.8%)
-$533.90 K(+244.2%)
-$1.31 M(+39.9%)
Dec 2014
-
-$155.10 K(-56.4%)
-$937.70 K(-16.4%)
Sep 2014
-
-$355.50 K(+32.7%)
-$1.12 M(+42.3%)
Jun 2014
-
-$267.80 K(+68.1%)
-$788.00 K(+35.6%)
Mar 2014
-$581.10 K
-$159.30 K(-53.0%)
-$581.30 K(+37.7%)
Dec 2013
-
-$339.10 K(+1455.5%)
-$422.00 K(+409.0%)
Sep 2013
-
-$21.80 K(-64.3%)
-$82.90 K(+35.7%)
Jun 2013
-
-$61.10 K
-$61.10 K

FAQ

  • What is Nemaura Medical annual EBITDA?
  • What is the all time high annual EBITDA for Nemaura Medical?
  • What is Nemaura Medical annual EBITDA year-on-year change?
  • What is Nemaura Medical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Nemaura Medical?
  • What is Nemaura Medical quarterly EBITDA year-on-year change?
  • What is Nemaura Medical TTM EBITDA?
  • What is the all time high TTM EBITDA for Nemaura Medical?
  • What is Nemaura Medical TTM EBITDA year-on-year change?

What is Nemaura Medical annual EBITDA?

The current annual EBITDA of NMRD is -$7.29 M

What is the all time high annual EBITDA for Nemaura Medical?

Nemaura Medical all-time high annual EBITDA is -$581.10 K

What is Nemaura Medical annual EBITDA year-on-year change?

Over the past year, NMRD annual EBITDA has changed by +$53.50 K (+0.73%)

What is Nemaura Medical quarterly EBITDA?

The current quarterly EBITDA of NMRD is -$155.40 K

What is the all time high quarterly EBITDA for Nemaura Medical?

Nemaura Medical all-time high quarterly EBITDA is -$21.80 K

What is Nemaura Medical quarterly EBITDA year-on-year change?

Over the past year, NMRD quarterly EBITDA has changed by $0.00 (0.00%)

What is Nemaura Medical TTM EBITDA?

The current TTM EBITDA of NMRD is -$4.50 M

What is the all time high TTM EBITDA for Nemaura Medical?

Nemaura Medical all-time high TTM EBITDA is -$61.10 K

What is Nemaura Medical TTM EBITDA year-on-year change?

Over the past year, NMRD TTM EBITDA has changed by $0.00 (0.00%)